Management & Board
| Board of Directors | |
 |
|
| Leonard Bell, M.D.: | Chief Executive Officer, Secretary, Treasurer, Director |
| David W. Keiser: | President and Chief Operating Officer, Director |
| Max Link, Ph.D.: | Chairman of the Board of Directors |
| Joseph A. Madri, Ph.D., M.D.: | Director |
| Larry L. Mathis : | Director |
| R. Douglas Norby : | Director |
| Alvin S. Parven: | Director |
| Ruedi Waeger, Ph.D.: | Director |
| Senior Management | |
| Leonard Bell, M.D.: | Chief Executive Officer, Secretary, Treasurer, Director |
| David W. Keiser: | President and Chief Operating Officer, Director |
| Stephen P. Squinto, Ph.D.: | Executive Vice President and Head of Research |
| Patrice Coissac : | Senior Vice President, General Manager and President of Alexion Europe SAS |
| Thomas I.H. Dubin, J.D.: | Senior Vice President and General Counsel |
| Nancy Motola, Ph.D.: | Senior Vice President, Regulatory Affairs and Quality |
| Scott A. Rollins, Ph.D.: | Senior Vice President, Drug Development and Project Management |
| Russell P. Rother, Ph.D.: | Senior Vice President, Research |
| Vikas Sinha, M.B.A., C.A. : | Senior Vice President and Chief Financial Officer |
| Paul W. Finnegan, M.D., M.B.A.: | Vice President, Global Strategic Marketing and Development |
| David Hallal: | Vice President, United States Commercial Operations |
| M. Stacy Hooks, Ph.D.: | Vice President, Manufacturing and Technical Services |
| Barry P. Luke: | Vice President, Finance, Assistant Secretary |
| Daniel N. Caron: | Executive Director, Operations and Engineering |
